Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target refers to the process by which toxins and drugs, when present in the gastrointestinal tract, are prevented from being absorbed into the bloodstream through their physical adsorption onto administered agents such as activated charcoal or resins. This is a common therapeutic mechanism in cases of oral poisoning or overdose, where the aim is to decrease the bioavailability of harmful substances. The adsorption process is a physicochemical phenomenon, not mediated by specific biological receptors or enzymes[1][2][3][4][5]. The implementation relies on substances with high surface area and affinity for toxins, administered orally, to bind and prevent GI absorption, ultimately leading to fecal excretion.
Physical adsorption onto solid phase materials in the GI lumen, preventing systemic absorption and promoting elimination[1][2][3][5]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adsorption of toxins and drugs in the gastrointestinal tract.